Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Adults who take the anti-inflammatory drug ibuprofen may reduce their risk of getting Parkinson's disease by about 27 percent compared to those who do not, said a study published Wednesday.
"There is no cure for Parkinson's disease, so the possibility that ibuprofen, an existing and relatively non-toxic drug, could help protect against the disease is captivating," said senior author Alberto Ascherio of the Harvard School of Public Health.
Parkinson's is a neurological disease that attacks the central nervous system and causes tremors and motor difficulty, mainly in people over 50, though it can strike younger people.
US-Canadian actor Michael J. Fox was diagnosed with Parkinson's when he was 30.
Scientists found an even greater effect when they compared ibuprofen - commonly found in the over the counter pain relievers Advil, Motrin and Nuprin - to aspirin, acetaminophen and other non-steroidal anti-inflammatory drugs (NSAIDs).
"We observed that men and women who used ibuprofen two or more times per week were about 38 percent less likely to develop Parkinson's disease than those who regularly used aspirin, acetaminophen, or other NSAIDs," said lead author Xiang Gao, also of Harvard.
"Our findings suggest that ibuprofen could be a potential neuroprotective agent against Parkinson's disease, however, the exact mechanism is unknown."
The study appears in the journal Neurology.
js/ksh/rl
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments